Vicarious Surgical CEO Adam Sachs to Present at Surgical Disruptive Technology Summit

Rhea-AI Summary

Vicarious Surgical Inc., a robotics technology company, announced that CEO Adam Sachs will participate in a panel discussion on surgical robots at the Surgical Disruptive Technology Summit on June 4, 2021, in Houston, Texas. The discussion, titled 'Surgical Robotics: The Next 5 Years,' will run from 7:00 to 9:00 p.m. CT. Founded in 2014, Vicarious focuses on improving surgical efficiency and patient outcomes using advanced robotic and virtual reality technologies. It holds the FDA's Breakthrough Device Designation, making it a leader in the field.

WALTHAM, Mass., May 27, 2021 /PRNewswire/ -- Vicarious Surgical Inc. ("Vicarious" or "Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, today announced that Adam Sachs, Co-Founder and Chief Executive Officer of Vicarious Surgical, will participate in a panel discussion on the future of surgical robots at the Surgical Disruptive Technology Summit in Houston, Texas on June 4, 2021.

Presentation Details

Title:     Surgical Robotics: The Next 5 Years
Date:    June 4, 2021
Time:    7:00 – 9:00 p.m. CT

About Vicarious Surgical

Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. The Company's novel surgical approach uses a combination of proprietary human-like surgical robots and virtual reality to transport surgeons inside the patient to perform minimally invasive surgery. The Company's technology was granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA), making it the first, and only, surgical robot to receive this designation from the FDA.*
The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla's Khosla Ventures, Eric Schmidt's Innovation Endeavors, Jerry Yang's AME Cloud Ventures, and Philip Liang's E15 VC. The Company is headquartered in Waltham, MA. 

Investor Inquiries:
Mike Piccinino, CFA
mike.piccinino@westwicke.com

Press and Media Inquiries:
Sean Leous
Sean.Leous@westwicke.com 
Phone + 1 646 866 4012

* As of the date of this press release, Vicarious Surgical is not aware of any surgical robotics company that has announced receiving Breakthrough Designation for a full robotics system.

View original content to download multimedia:http://www.prnewswire.com/news-releases/vicarious-surgical-ceo-adam-sachs-to-present-at-surgical-disruptive-technology-summit-301301287.html

SOURCE Vicarious Surgical

FAQ

What event will Adam Sachs attend on June 4, 2021?

Adam Sachs will attend the Surgical Disruptive Technology Summit in Houston, Texas.

What is the topic of the panel discussion at the Surgical Disruptive Technology Summit?

The panel discussion is titled 'Surgical Robotics: The Next 5 Years.'

What time will the Surgical Disruptive Technology Summit panel discussion take place?

The panel discussion will take place from 7:00 to 9:00 p.m. CT.

What technology does Vicarious Surgical focus on?

Vicarious Surgical focuses on advanced robotics and virtual reality technologies for surgical procedures.

What designation has Vicarious Surgical received from the FDA?

Vicarious Surgical's technology has received the Breakthrough Device Designation from the FDA.